Extended Data Fig. 1: Vaccination schedule and sample collection.
From: BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
Study participants received a priming dose with BNT162b2 on day 1 and a booster dose on day 22 ± 2. Sera were obtained on day 1 (pre-prime), day 8 ± 1 (post-prime), day 22 ± 2 (pre-boost), day 29 ± 3, day 43 ± 4, day 50 ± 4 and day 85 ± 7 (post-boost). PBMCs were obtained on day 1 (pre-prime), day 29 ± 3, day 43 ± 4 and day 85 ± 7 (post-boost).
